ADDF Supports Madera Biosciences to Advance Small Molecule Drugs that Upregulate ApoE


The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded follow-on funding of $298,500 to Madera Biosciences, Inc. to further develop its small molecule drugs designed to clear accumulated beta-amyloid from the brain and thus halt or reverse the progression of Alzheimer’s disease.

Read Release

Go to top